Google Changes EU Spam Policy Amid Antitrust Scrutiny 
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan 
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook 
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question 
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook 
Honda, Nissan Eye Shared Vehicle Software Platform by 2029 
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 
Street Poller Media and The Boom of the Street Interview Ad Industry 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’ 
Meta, U.S. States Discuss Settlement in Teen Addiction Trial 
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
PayPal Shares Sink as $50 Billion Takeover Bid Collapses 
Add as a preferred source on Google
Pompano Beach, Fla., Dec. 09, 2015 (GLOBE NEWSWIRE) -- DS Healthcare Group’s flagship products are now selling in Walmart, one of Brazil’s largest retailers. With this addition, DS Laboratories further expands its global retail footprint as part of the company’s omni-channel approach and continued dedication to delivering its breakthroughs to consumers worldwide.
Brazilian customers can view our product selection and order at the following link: https://www.walmart.com.br/busca/?ft=ds+laboratories&PS=20
Brazil remains the world's third largest consumer market for toiletries and stands as the world’s second largest market for men’s and children’s hair care products. The partnership with Walmart is expected to drive significant revenue growth for the company in Brazil.
About DS Healthcare Group
DS Healthcare Group Inc. is a leader in the development of biotechnology for topical therapies. It markets through online channels, specialty retailers, distributors, pharmacies, and salons. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects. For more information on DS Health Group's flagship brand, visit www.dslaboratories.com or www.facebook.com/DS.Labs
Forward-looking statements
Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov
Investor Relations DS Healthcare Group (888) 404-7770 ext. 3 [email protected]
